AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lares-Asseff, I.
Right arrow Articles by Carbajal-Rodríguez, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lares-Asseff, I.
Right arrow Articles by Carbajal-Rodríguez, L.
Agricola
Right arrow Articles by Lares-Asseff, I.
Right arrow Articles by Carbajal-Rodríguez, L.
American Journal of Clinical Nutrition, Vol. 69, No. 2, 318-324, February 1999
© 1999 American Society for Clinical Nutrition

Original Research Communications

Influence of nutritional status on the pharmacokinetics of acetylsalicylic acid and its metabolites in children with autoimmune disease1,2

Ismael Lares-Asseff, Janett Flores-Pérez, Hugo Juárez-Olguín, Martha Ramírez-Lacayo, Arturo Loredo-Abdalá and Luis Carbajal-Rodríguez

Background: It is unknown whether nutritional status associated with autoimmune disease alters the pharmacokinetics of acetylsalicylic acid (ASA) and its metabolites.

Objective: We studied the effects of the nutritional status of children with autoimmune disease on the disposition of ASA and its metabolites.

Design: A prospective, open-label study was performed with 21 children aged 3–15 y who required ASA therapy. Children received 25 mg ASA/kg orally. Blood samples were drawn before and 0.5, 1.0, 2.0, 4.0, 8.0, 12.0, and 24.0 h after ASA administration; urine samples were collected at different intervals. ASA and its metabolites were measured in plasma and urine. Nutritional status was assessed previously.

Results: The ASA maximum plasma concentration, area under the curve, and total clearance were significantly lower in underweight children than in normal-weight children. The elimination rate constants of gentisic acid (GA), salicyluric acid (SUA), and salicylic acid (SA) in plasma were slower for underweight children than for normal-weight children. The distribution volume of SUA increased significantly (r = 0.92) when the deficit percentage in weight-for-height increased. Underweight children excreted less GA and SA, but more SUA, than did normal-weight children.

Conclusions: These observations suggest a decrease in the hydrolysis and oxidative reactions of the metabolic pathway of ASA and its metabolites in underweight children. The study illustrates the need for pharmacokinetic data to establish the individual doses of drugs, particularly in conditions that alter nutritional status.

Key Words: Salicylic acid metabolism • acetylsalicylic acid • nutritional status • pharmacokinetics • children • juvenile rheumatoid arthritis • acute rheumatic fever • gentisic acid • salicyluric acid • salicylic acid






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by The American Society for Nutrition